Filing Flows › Verastem (VSTM) › Q4 2025
Verastem (VSTM) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 4, 2026
Verastem (VSTM) reported revenue of $17.5M for the fourth quarter 2025 (Q4 2025) and +56% from the quarter before. Operating margin was -236.5%, net loss $32.9M (187.7% of revenue).
Verastem, Q4 2025: revenue $17.5M, operating margin -236.5%, net loss $32.9M, operating cash flow −$30.0M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.5M | +56% | — |
| Operating profit | −$41.5M | — | — |
| Net earnings | −$32.9M | — | — |
| Operating cash flow | −$30.0M | — | — |
What changed
Revenue was $17.5M in Q4 2025, up 56% from the previous quarter.
Operating costs exceeded revenue by $41.5M, an operating margin of -236.5%. The quarter ended with a net loss of $32.9M, narrower than the previous quarter's $98.5M loss. Non-operating items added $8.6M, -26% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$30.0M. Non-cash charges added back $298K of depreciation and amortization and $2.0M of share-based compensation.
Questions
What was Verastem's revenue in the fourth quarter 2025?
Verastem (VSTM) reported revenue of $17.5M for the fourth quarter 2025 (Q4 2025) and +56% from the quarter before.
Was Verastem profitable in the fourth quarter 2025?
Operating loss was $41.5M (-236.5% of revenue) and net loss $32.9M.
Source: Verastem 10-K on SEC EDGAR.